Martina Kralinger

Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema

Claus Zehetner, Rudolf Kirchmair, Stefan Huber et al. · British Journal of Ophthalmology · 2013 · 160 citations

Medicine, Ophthalmology, Pharmacotherapy +17

Systemic levels of vascular endothelial growth factor before and after intravitreal injection of aflibercept or ranibizumab in patients with age‐related macular degeneration: a randomised, prospective trial

Claus Zehetner, Martina Kralinger, Yasha S. Modi et al. · Acta Ophthalmologica · 2014 · 102 citations

Medicine, Ophthalmology, Pharmacotherapy +16

Pharmacokinetics of Systemic Versus Focal Carboplatin Chemotherapy in the Rabbit Eye: Possible Implication in the Treatment of Retinoblastoma

Brandy C. Hayden, Maria-Elena Jockovich, Timothy G. Murray et al. · Investigative Ophthalmology & Visual Science · 2004 · 87 citations

Medicine, Pharmacokinetics, Pharmacology +17

Ocular aspirin distribution: a comparison of intravenous, topical, and coulomb-controlled iontophoresis administration.

M. Voigt, Martina Kralinger, G. Kieselbach et al. · PubMed · 2002 · 49 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Correlation of vascular endothelial growth factor plasma levels and glycemic control in patients with diabetic retinopathy

Claus Zehetner, Rudolf Kirchmair, Martina Kralinger et al. · Acta Ophthalmologica · 2013 · 39 citations

Medicine, Endocrinology, Ophthalmology +14